Aflatoxin and Sclerotia Production in Clinical Isolates of Aspergillus flavus Group
Backgrounds: To obtain information about clinical isolates of Aspergillus flavus group. Methods: We examined 55 isolates [45 clinical, 10 reference (6 from culture collections, 4 local reference)] for toxicology, growth rates, and morphological and physiological characteristics. Modified Czapek Agar...
Saved in:
Main Authors: | P Dehghan (Author), F Zaini (Author), M Mahmoudi (Author), A Jebali (Author), P Kordbacheh (Author), S Rezaei (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2008-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aflatoxin and Sclerotia Production in Clinical Isolates of Aspergillus Flavus Group
by: P Kordbacheh, et al.
Published: (2008) -
Detection of Aflr Gene and Toxigenicity of Aspergillus flavus Group Isolated from Patients with Fungal Sinusitis
by: P Dehghan, et al.
Published: (2008) -
Detection of Aflr Gene and Toxigenicity of Aspergillus flavus Group Isolated from Patients with Fungal Sinusitis
by: P Dehghan, et al.
Published: (2008) -
Candida Parapsilosis as a Potent Biocontrol Agent against Growth and Aflatoxin Production by Aspergillus Species
by: F Niknejad, et al.
Published: (2012) -
Candida parapsilosis as a Potent Biocontrol Agent against Growth and Aflatoxin Production by Aspergillus Species
by: F Niknejad, et al.
Published: (2012)